Designed specifically for bioreactor-scale workflows, the system reportedly requires less than 15 minutes of hands-on time.
A structurally tuned HPV cancer SNA vaccine boosts CD8⁺ T‑cell responses and slows tumor growth in mice and patient‑derived spheroids, a study shows.